- Home
- NCSM vs HLVX Comparison
NCSM vs HLVX Comparison
Compare NCSM & HLVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCSM
- HLVX
- Stock Information
- Founded
- NCSM 2006
- HLVX 2020
- Country
- NCSM United States
- HLVX United States
- Employees
- NCSM N/A
- HLVX N/A
- Industry
- NCSM Oilfield Services/Equipment
- HLVX Biotechnology: Pharmaceutical Preparations
- Sector
- NCSM Energy
- HLVX Health Care
- Exchange
- NCSM Nasdaq
- HLVX Nasdaq
- Market Cap
- NCSM 76.3M
- HLVX 83.7M
- IPO Year
- NCSM 2017
- HLVX 2022
- Fundamental
- Price
- NCSM $29.76
- HLVX $2.12
- Analyst Decision
- NCSM
- HLVX Hold
- Analyst Count
- NCSM 0
- HLVX 5
- Target Price
- NCSM N/A
- HLVX $2.33
- AVG Volume (30 Days)
- NCSM 7.8K
- HLVX 434.4K
- Earning Date
- NCSM 07-30-2025
- HLVX 08-07-2025
- Dividend Yield
- NCSM N/A
- HLVX N/A
- EPS Growth
- NCSM N/A
- HLVX N/A
- EPS
- NCSM 3.27
- HLVX N/A
- Revenue
- NCSM $168,704,000.00
- HLVX N/A
- Revenue This Year
- NCSM $7.17
- HLVX N/A
- Revenue Next Year
- NCSM $5.44
- HLVX N/A
- P/E Ratio
- NCSM $9.17
- HLVX N/A
- Revenue Growth
- NCSM 18.16
- HLVX N/A
- 52 Week Low
- NCSM $16.66
- HLVX $1.34
- 52 Week High
- NCSM $38.95
- HLVX $2.16
- Technical
- Relative Strength Index (RSI)
- NCSM 45.45
- HLVX 63.08
- Support Level
- NCSM $29.61
- HLVX $1.98
- Resistance Level
- NCSM $30.82
- HLVX $2.12
- Average True Range (ATR)
- NCSM 1.05
- HLVX 0.08
- MACD
- NCSM -0.08
- HLVX 0.01
- Stochastic Oscillator
- NCSM 23.50
- HLVX 89.66
About NCSM NCS Multistage Holdings Inc.
NCS Multistage Holdings Inc is a provider of engineered products and support services that facilitate the optimization of oil and natural gas well construction, well completions and field development strategies. NCS provides its products and services to exploration and production companies for use in onshore wells, predominantly wells that have been drilled with horizontal laterals in unconventional oil and natural gas formations. The company's offering is its fracturing systems products and services, which enable efficient pinpoint stimulation: the process of individually stimulating each entry point into a formation targeted by an oil or natural gas well. It sell products and services in North America and in selected international markets.
About HLVX HilleVax Inc.
HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.